Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Consumer Non Durables » Food Major Diversified
|BYND||Beyond Meat, Inc.||1.20%||145.48||0.0%||$484.93m|
|MDLZ||Mondelez International, Inc.||-1.63%||53.16||1.1%||$439.29m|
|KHC||The Kraft Heinz Co.||-2.39%||36.38||0.9%||$322.19m|
|GIS||General Mills, Inc.||-1.63%||54.93||2.2%||$217.36m|
|CAG||Conagra Brands, Inc.||-1.91%||33.91||1.3%||$126.72m|
|CPB||Campbell Soup Co.||-0.24%||45.54||2.7%||$106.65m|
|BGS||B&G Foods, Inc.||-2.26%||30.32||11.3%||$73.42m|
|THS||TreeHouse Foods, Inc.||-2.59%||50.07||10.0%||$47.90m|
|TTCF||Tattooed Chef, Inc.||-0.35%||19.93||0.0%||$36.11m|
|SMPL||The Simply Good Foods Co.||0.62%||29.17||0.0%||$14.84m|
|LEXX||Lexaria Bioscience Corp.||-2.13%||5.98||0.0%||$2.63m|
Lexaria Bioscience Corp. is a proprietary drug delivery technology company. Its technology DehydraTECH, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier ingestion methods and increasing the effectiveness of fat-soluble active molecules, thereby lowering overall dosing. The company's technology can be applied to many different ingestible product formats, including foods, beverages, oral suspensions, tablets, and capsules. DehydraTECH increases bio-absorption, reduces time of onset, and masks unwanted tastes for orally administered bioactive molecules, including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products; and to a tobacco producer for the development of smokeless, oral-based nicotine products. The company was founded on December 9, 2004 and is headquartered in Kelowna, Canada.